- Previous Close
44.78 - Open
44.92 - Bid 46.15 x 800
- Ask 46.27 x 800
- Day's Range
44.79 - 46.38 - 52 Week Range
38.27 - 65.03 - Volume
647,627 - Avg. Volume
640,342 - Market Cap (intraday)
2.58B - Beta (5Y Monthly) 2.00
- PE Ratio (TTM)
-- - EPS (TTM)
-2.21 - Earnings Date Feb 20, 2025 - Feb 24, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
66.30
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
www.enovis.com6,550
Full Time Employees
December 31
Fiscal Year Ends
Sector
Specialty Industrial Machinery
Industry
Recent News: ENOV
View MorePerformance Overview: ENOV
Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ENOV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ENOV
View MoreValuation Measures
Market Cap
2.50B
Enterprise Value
3.88B
Trailing P/E
--
Forward P/E
14.29
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.23
Price/Book (mrq)
0.75
Enterprise Value/Revenue
1.94
Enterprise Value/EBITDA
21.84
Financial Highlights
Profitability and Income Statement
Profit Margin
-5.95%
Return on Assets (ttm)
0.37%
Return on Equity (ttm)
-3.56%
Revenue (ttm)
2B
Net Income Avi to Common (ttm)
-121.38M
Diluted EPS (ttm)
-2.21
Balance Sheet and Cash Flow
Total Cash (mrq)
35.42M
Total Debt/Equity (mrq)
42.43%
Levered Free Cash Flow (ttm)
-80.95M